Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer
Xiaodan Sun, Peiyan Zhao, Hui Li, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 21

Showing 21 citing articles:

MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Ka Iong Chan, Siyuan Zhang, Guodong Li, et al.
Aging and Disease (2024) Vol. 15, Iss. 2, pp. 640-640
Open Access | Times Cited: 18
The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
Philippe Icard, Luca Simula, Ludovic Fournel, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100852-100852
Open Access | Times Cited: 39
Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future
Wei Guan, Qi Wang
Phytomedicine (2023) Vol. 118, pp. 154938-154938
Closed Access | Times Cited: 14
Annexin A2 binds the 3′-UTR of H2AX mRNA and regulates histone-H2AX-derived hypoxia-inducible factor 1-alpha activation
Shiyin Zhang, Yushi Wang, Yang Li, et al.
Cellular Signalling (2025), pp. 111781-111781
Closed Access
Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation
Xiaodan Sun, Ying Cheng
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113912-113912
Open Access | Times Cited: 21
Phytotherapy in Integrative Oncology—An Update of Promising Treatment Options
Amy Marisa Zimmermann-Klemd, Jakob K. Reinhardt, Moritz Winker, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3209-3209
Open Access | Times Cited: 20
Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy
Fahad Alsaikhan
Environmental Research (2023) Vol. 237, pp. 116951-116951
Closed Access | Times Cited: 12
20(S)-Ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src/STAT3 signaling
Jun‐Kui Li, Xiaoli Jiang, Zhu Zhang, et al.
Journal of Ginseng Research (2024) Vol. 48, Iss. 6, pp. 559-569
Open Access | Times Cited: 4
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Oleg Shuvalov, Yulia Kirdeeva, Alexandra Daks, et al.
Antioxidants (2023) Vol. 12, Iss. 11, pp. 2012-2012
Open Access | Times Cited: 10
Programmed death-ligand 1 signaling and expression are reversible by lycopene via PI3K/AKT and Raf/MEK/ERK pathways in tongue squamous cell carcinoma
Mingjing Peng, Songqing Fan, Junjun Li, et al.
Genes & Nutrition (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 14
Fucoxanthin suppresses the malignant progression of ovarian cancer by inactivating STAT3/c-Myc signaling.
Zhan Zhang, Youqun Wang, Jianhua Li
PubMed (2023) Vol. 15, Iss. 4, pp. 2528-2540
Closed Access | Times Cited: 8
The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention
Dong Wang, Fangyuan Wang, Xianbin Kong, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113376-113376
Open Access | Times Cited: 12
Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells
Jae Eun Park, Hwee Won Ji, Hyeon Woo Kim, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 06, pp. 1703-1717
Closed Access | Times Cited: 9
Potential of ginsenoside Rh2and its derivatives as anti-cancer agents
Keke Li, Zhongyu Li, Lei Men, et al.
Chinese Journal of Natural Medicines (2022) Vol. 20, Iss. 12, pp. 881-901
Closed Access | Times Cited: 8
Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment
Mei Tang, Haidong Deng, Kailu Zheng, et al.
Toxicology and Applied Pharmacology (2023) Vol. 460, pp. 116378-116378
Closed Access | Times Cited: 4
Tripartite Motif-containing Protein 11 Silencing Inhibits Proliferation and Glycolysis and Promotes Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Inactivating Signal Transduction and Activation of Transcription Factor 3/c-Myc Signaling
Tingting Xuan
Journal of physiological investigation. (2024) Vol. 67, Iss. 1, pp. 37-46
Open Access | Times Cited: 1
Influence of Ginsenoside Rh2 on Cardiomyocyte Pyroptosis in Rats with Acute Myocardial Infarction
Wan-mei Song, Bin Dai, Yuntang Dai
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 7
Identification of 20(S)-Ginsenoside Rh2 as a Potential EGFR Tyrosine Kinase Inhibitor
Yuan Liang, Jingqi Zhao, Haoyang Zou, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 4
Anti-Warburg Mechanism of Ginsenoside F2 in Human Cervical Cancer Cells via Activation of miR193a-5p and Inhibition of β-Catenin/c-Myc/Hexokinase 2 Signaling Axis
Na‐Ri Shin, Hyo‐Jung Lee, Deok Yong Sim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9418-9418
Open Access
Juzaowan Suppresses Glycolysis in Breast Cancer Cells by Inhibiting the STAT3/C-Myc Axis
Yuan Zhou, Liumei Lin, Fei Li, et al.
Nutrition and Cancer (2024), pp. 1-15
Closed Access
B7-H3 Regulates Glucose Metabolism in Neuroblastom via Stat3/c-Met Pathway
Xiaomin Zhu, Yingzuo Shi, Jian Wang
Applied Biochemistry and Biotechnology (2023) Vol. 196, Iss. 3, pp. 1386-1398
Closed Access | Times Cited: 1
Page 1

Scroll to top